EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Active Ingredients and Mechanisms of Crataegi fructus Extract in Alleviating MAFLD via the AMPK/PPAR Pathway by Multi-Omics

Xing Yan, Lulu Zheng, Yuexiang Xiao, Ya Xu, Qing Xu, Lihua Zeng, Siqi Hu, Deqing Ruan, Zhixin Wang iD

Molecules · 16.06.2026 · 31 (12) · 2118

DOI: 10.3390/molecules31122118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 16.06.2026. Verfasst von Xing Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Province Key Laboratory of Sustainable Utilization of Traditional Chinese Medicine Resources & Jiangxi Province Key Laboratory of Traditional…. Hauptthemen laut MEDLINE: Crataegus, Signal Transduction, AMP-Activated Protein Kinases, Plant Extracts. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Public Welfare Research Institutes, Scientific Research Foundation for the introduction of talent, General Projects of Jiangxi Provincial Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fruit of Crataegi fructus (CF) is a traditional “medicine food” herb widely used for its lipid-lowering properties, but its active ingredients and mechanisms against metabolic dysfunction-associated fatty liver disease (MAFLD) remain poorly understood. This study employed an integrated multi-omics approach, combining serum metabolomics, liver transcriptomics, weighted gene co-expression network analysis (WGCNA), network pharmacology, and molecular docking, to systematically investigate the effects of CF extract (CFE) in a high-fat diet (HFD)-induced mouse model of MAFLD. Our analysis revealed that CFE treatment significantly reduced body weight gain (p < 0.01), improved glucose tolerance and insulin sensitivity (p < 0.01), and alleviated hepatic steatosis, as evidenced by reduced lipid accumulation and decreased NAS scores (p < 0.001). Metabolomics analysis showed that CFE reversed HFD-induced disturbances in serum fatty acids, glycerophospholipids, and bile acid metabolites. Transcriptomics further revealed that the AMPK and PPAR signalling pathways were critically involved in the regulation of lipid metabolism by which CFE alleviated MAFLD. Consistently, CFE treatment resulted in significant upregulation of AMPK and PPARα expression (p < 0.001) and downregulation of CD36 and DPP4 (p < 0.001), as confirmed by Western blotting and qPCR. Furthermore, integration of WGCNA and network pharmacology pinpointed chlorogenic acid (CA), ursolic acid (UA), and oleanolic acid (OA) as the primary bioactive components, and their lipid-lowering effects were validated in FFA-treated THLE-2 cells. In conclusion, this study offers preliminary insights into the lipid-lowering mechanisms of CFE via regulation of the AMPK/PPARα/CD36/DPP4 signalling pathway and support its further development as a functional food ingredient for MAFLD prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CrataegusSignal TransductionAMP-Activated Protein KinasesPlant ExtractsNon-alcoholic Fatty Liver DiseasePeroxisome Proliferator-Activated ReceptorsAnimalsMiceFruitLipid MetabolismMultiomicsMetabolomicsDiet, High-FatMaleMolecular Docking SimulationDisease Models, AnimalLiver

Stichwörter der Autor:innen

Crataegi fructusactive ingredientslipid metabolismmetabolic dysfunction-associated fatty liver disease (MAFLD)multi-omics

Substanzen

AMP-Activated Protein KinasesPlant Extractscrataegus extractPeroxisome Proliferator-Activated Receptors

Autor:innen und Institutionen

  • Jiangxi Province Key Laboratory of Sustainable Utilization of Traditional Chinese Medicine Resources & Jiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medic…
  • Jiangxi Health Industry Institute of Traditional Chinese Medicine, Nanchang 330115, China.
  • School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
  • Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine, Kunming 650500, China.

ORCID-Profile: Zhixin Wang

Förderung

  • Fundamental Research Funds for the Central Public Welfare Research Institutes
  • Scientific Research Foundation for the introduction of talent
  • General Projects of Jiangxi Provincial Administration of Traditional Chinese Medicine
  • Jiangxi "Ganpo Talent" Innovation Leader Program
  • Jiangxi “Ganpo Talent” Innovation Leader Program

Zitieren

APA

Yan, X., Zheng, L., Xiao, Y., Xu, Y., Xu, Q., Zeng, L., Hu, S., Ruan, D., & Wang, Z. (2026). Exploring Active Ingredients and Mechanisms of Crataegi fructus Extract in Alleviating MAFLD via the AMPK/PPAR Pathway by Multi-Omics. Molecules, 31(12), 2118. https://doi.org/10.3390/molecules31122118

Vancouver

Yan X, Zheng L, Xiao Y, Xu Y, Xu Q, Zeng L, et al. Exploring Active Ingredients and Mechanisms of Crataegi fructus Extract in Alleviating MAFLD via the AMPK/PPAR Pathway by Multi-Omics. Molecules. 2026;31(12):2118. doi:10.3390/molecules31122118

BibTeX
@article{Yan2026,
  author = {Yan, Xing and Zheng, Lulu and Xiao, Yuexiang and Xu, Ya and Xu, Qing and Zeng, Lihua and Hu, Siqi and Ruan, Deqing and Wang, Zhixin},
  title = {Exploring Active Ingredients and Mechanisms of Crataegi fructus Extract in Alleviating MAFLD via the AMPK/PPAR Pathway by Multi-Omics},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {12},
  pages = {2118},
  doi = {10.3390/molecules31122118}
}
Kostenlos starten →